Rett Syndrome

Management of Genetic Syndromes: Third Edition

Volumn , Issue , 2010, Pages 677-691

  Smeets, Eric E ^a,b   Schrander Stumpel, Connie T R M ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Defective protein; Methylated DNA; Neurodevelopmental disorder; Rett syndrome; X chromosome

Indexed keywords

EID: 84860158987     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470893159.ch45     Document Type: Chapter

References (59)

1. Amir R, Van den Veyver I, Wan M, Tran C, Francke U, Zoghbi H (1999) Rett syndrome is caused by mutations in X-linked LMeCP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185-188.
2. Armstrong DD (2002) Neuropathology of Rett syndrome. MRDD Res Rev 8:72-76.
3. Armstrong DD, Kinney HC (2001) Rett disorder and the developing brain. In: The Neuropathology of the Rett Disorder, KerrA, Witt-Engerstrom I,eds, Oxford: Oxford University Press, pp. 57-84.
4. Armstrong DD, Dunn JK, Antalffy B (1998) Decreased dendritic branching in frontal, motor, limbic cortex in Rett syndrome compared with trisomy 21. J Neurpathol Exp Neurol 57:1013-1017.
5. Bourdon V, Philippe C, Labrune O, Amsallem D, Arnould C, Jonveaux P (2001) A detailed analysis of the MECP2 gene: Prevalence of recurrent mutations and gross rearrangements in Rett syndrome patients. Hum Genet 108:43-50.
6. Chandler SP, Guschin D, Landsberger N, Wolffe AP (1999) The methyl-CpG-binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry 38:7008-7018.
7. Cheadly JP, Gill H, Fleming N, Maynard J, Kerr A, Leonard H, Krawczak M, Cooper DN, Lynch S, Thomas N, Hughes H, Hulten M, Ravine D, Sampson JR, Clark A (2000) Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: Correlation of disease severity with mutation type and localisation. Hum Mol Genet 9:1119-1129.
8. Chen W, Chang Q, Lin Y, Meissner A, West A, Griffith E, Jaenisch R, Greenberg M (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MECP2. Science 302:885.
9. Ellaway C, Christodoulou J (2001) Rett syndrome: Clinical char-acteristics and recent genetic advances. Disabil Rehabil 23:98-106.
10. Flett P (2003) Rehabilitation of spasticity and related problems in childhood cerebral palsy. J Paediatr Child Health 39:6-14.
11. Friedlander A, Yagiel J, Paterno V, Mahler M (2003) The patho-physiology, medical management and dental implications of fragile X, Rett, and Prader-Willi syndromes. J Calif Dent Assoc 31:693-702.
12. Girard M, Couvert P, Carrie A, Tardieu M, Chelly J, Beldjord C, Bienvenue T (2001) Parental origin of de novo MeCP2 mutations in Rett syndrome. .Eur J Hum Genet 9:231-236.
13. Hagberg B, Gilberg C (1993) In: Rett Syndrome, Clinical, Biologi-cal Aspects, Rett Variants-Rettoid Types, Clinics in Develop-mental Medicine, Vol 127. MacKeith, Cambridge: Cambridge University Press, pp. 40-60.
14. Hagberg B, Skjeldal O (1994) Rett variants: A suggested model for inclusion criteria. Pediatr Neurol 11:5-l 1.
15. Hagberg B, Aicardi J, Dias K, Ramos O (1983) A progressive syndrome of autism, dementia, ataxia and loss of purposeful handuse in girls: Rett's syndrome: Report of 35 cases. Ann Neurol 14:471-479.
16. Hagberg B, Goutieres F, Hanefeld F, Rett A, Wilson J (1990) Rett syndrome: Criteria for inclusion and exclusion. Brain Dev 12:47-8.
17. Hagberg B, Stenbom Y, Witt-Engerstrom I (2001) Head growth in Rett syndrome. Brain Dev 23 (Suppl 1): S227-S229.
18. Hagberg B, Hanefeld F, Percy A, Skjeldal O (2002) An update on clinically applicable diagnostic criteria in Rett syndrome. Com-ments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden, Germany, 11 September 2001. Eur J Paediatr Neurol 6:293-297.
19. Huppke P, Laccone F, Kramer N, Engel W, Hanefeld F (2000) Rett syndrome: Analysis of MECP2 and clinical characterization of 31 patients. Hum Mol Genet 9:1369-1375.
20. Huppke P, Roth C, Christen HJ, Brockmann K, Hanefeld F (2001) Endocrinologic study on growth retardation in Rett syndrome. Ada Paediatr 90:1257-1261.
21. Ishikawa A, Goto T, Narasaki M, Yokochi K, Kitahara H, Fu-kuyama Y (1978) A new syndrome (?) of progressive psycho-motor retardation with peculiar stereotyped movements and autistic tendency: A report of three cases. Brain Dev 3: 258.
22. Julu PO (2001) The central autonomic disturbance in Rett syn-drome. In: Rett Disorder and the Developing Brain, Kerr A, Witt- Engerstrom I,eds, Oxford, New York: Oxford University Press, pp. 131-181.
23. Julu PO, Witt-Engerstrom I (2005) Assessment of the maturity-related brainstem functions reveals the heterogeneous pheno-types and facilitates clinical management of Rett syndrome. Brain Dev 27 (Suppl 1): S43-S53.
24. Julu PO, Kerr AM, Hansen S, Apartopoulos F, Jamal GA (1997) Immaturity of medullary cardiorespiratory neurones leading to inappropriate autonomic reactions as a likely cause of sudden death in Rett's syndrome. Arch Dis Child 71:464-465.
25. Julu PO, Kerr AM, Apartopoulos F, Al-Rawas S, Wiit-Engerstrom L, Engerstrom L, Jamal GA, Hansen S (2001) Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder. Arch Dis Child 85:29-37.
26. Julu PO, Witt-Engerstrom I, Hansen S, Apartopoulos F, Witt B, Pini G, Delamont RS, Smeets EE (2008) Clinical update addressing the cardiorespiratory challenges in medicine posed by Rett syndrome: The Froso Declaration. Lancet 371: 1981-1983.
27. Kerr AM (1992) In: Mental Retardation and Medical Care: Rett Syndrome British Longitudinal Study (1982-1990) and 1990 Survey, Roosendaal JJ,ed. Zeist: Kerckbosch Publisher, pp. 143-145.
28. Kerr A, Witt-Engerstrom I (2001) Rett Disorder and the Developing Brain, Oxford: Oxford University Press.
29. Kerr A, Julu P, Hansen S, Apartopoulos F (1998) Serotonin and breathing dysrhythmia in Rett syndrome. In: New Development in Child Neurology, Perat MV,ed. Bologna: Monduzzi Editore, pp. 191-195.
30. Kerr A, Nomura Y, Armstrong D, Anvret M, Belichenko PV, Budden S, Cass H, Christodoulou J, Clarke A, Ellaway C, d'Esposito M, Francke u Hulten M, Julu P, Leonard H, Naidu S, Schanen C, Webb T, Engerstrom I, Yamashita Y, Segawa M (2001) Guidelines for reporting clinical features in cases with MECP2 mutations. Brain Dev 23:208-211.
31. LaSalle JM, Goldstine J, Balmer D, Greco CM (2001) Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum Mol Genet 10:1729-1740.
32. Laskawi R (2008) The use of botulinum toxin in head and face medicine: An interdisciplinary field. Head Face Med 4:5.
33. Leonard H, Silberstein J, Falk R, Houwink-Manville I, Ellaway C, Raffaele LS, Witt-Engerstrom I, Schanen C (2001) Occurrence of Rett syndrome in boys. J Child Neurol 16:333-338.
34. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun Y (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302:890.
35. McArthur A, Budden S (1998) Sleep dysfunction in Rett syndrome: A trial of exogenous melatonin treatment. Dev Med Child Neurol 40:186-192.
36. Miyamoto A, Oki J, Takahashi S, Okuno A (1999) Serum melatonin kinetics and long-term melatonin treatment for sleep disorders in Rett syndrome. Brain Dev 21:59-62.
37. Moog U, Smeets E, van Roozendaal K, Schoenmakers S, Herbergs J, Schoonbrood-Lenssen A, Schrander-Stumpel C (2003) Neuro-developmental disorders in males related to the gene causing Rett syndrome in females (MECP2). Eur J Paediatr Neurol 7:5-12.
38. Nan X, Tate P, Li E, Bird A (1996) DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol 10: 414-21.
39. Nan X, Campoy J, Bird A (1997) MeCP is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88:471-481.
40. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-389.
41. Nectoux J, Bahi-Buisson N, Guellec I, Coste J, De Roux N, Rosas H, Tardieu M, Chelly J, Bienvenu T (2008) The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome. Neurology 70 (Pt 2): 2145-2151.
42. Nomura Y, Segawa M (1992) Motor symptoms of the Rett syn-drome: Abnormal muscle tone, posture, locomotion and stereo-typed movement. Brain Dev 14 (Suppl): S21-S28.
43. Nomura Y, Segawa M, Higurashi M (1985) Rett syndrome-an early catecholamine and indolamine deficient disorder?. Brain Dev 7:334-341.
44. Reilly S, Cass H (2001) Growth and nutrition in Rett syndrome. Disabil Rehabil 23:118-128.
45. Rett A (1966) Uber ein cerebral-atrophisches Syndrom bei Hyper-ammonamie. Wien Med Wochenschr 116:7.
46. Ribeiro R, Romano A, Birman E, Mayer M (1997) Oral manifesta-tions in Rett syndrome: A study of 17 cases. Pediatr Dent 19:349-352.
47. Schanen NC, Dahle EJ, Capozzoli F, Holm VA, Zoghbi HY, Francke U (1997) A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map. Am J Hum Genet 61:634-641.
48. Schollen E, Smeets E, Deflem E, Fryns JP, Matthijs G (2003) Gross rearrangements in the MECP2 gene in three patients with Rett syndrome: Implications for routine diagnosis of Rett syndrome. HumMutat 22:116-120.
49. Schultz R, Glaze D, Motil K, Hebert D, Percy A (1998) Hand and foot growth failure in Rett syndrome. J Child Neurol 13:71-74.
50. Smeets E, Schollen E, Moog U, Matthijs G, Herbergs J, Smeets H, Curfs L, Schrander-Stumpel C, Fryns JP (2003) Rett syndrome in adolescent and adult females: Clinical and molecular genetic findings. Am J Med Gen 122A:227-233.
51. Smeets E, Julu P, van Waardenburg D, Witt-Engerstrom I, Hansen S, Apartopopoulos F, Curfs L, Schrander-Stumpel C (2006) Management of a severe forceful breather with Rett syndrome using carbogen. Brain Dev 28:625-632.
52. Steffenburg U, Hagberg G, Hagberg B (2001) Epilepsy in a repre-sentative series of Rett syndrome. Acta Paediatr 90:34-39.
53. Tao J, Van Esch H, Hagedorn-Greiwe M, Hoffmann K, Moser B, Raynaud M, Sperner J, Fryns JP, Schwinger E, Gecz J, Ropers HH, Kalscheuer VM (2004) Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet 75:1149-1154.
54. Wan M, Zhao K, Francke U (2001) MeCP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome. Hum Mol Genet 10:1085-1092.
55. Witt-Engerstrom I (1990) Rett Syndrome in Sweden. Acta Paediatr Scand 369 (Suppl): 1-60.
56. Yaron Y, Ben Zeev B, Shomrat R, Bercovich D, Naiman T, Orr-Urtreger A (2002) MECP2 mutations in Israel: Implications for molecular analysis, genetic counseling and prenatal diagnosis in Rett syndrome. Hum Mutat 20:323-324.
57. Yntema HG, Oudakker AR, Kleefstra T, Hamel BC, van Bokhoven H, Chelly J, Kalscheuer VM, Fryns JP, Raynaud M, Moizard MP, Moraine C (2002) In-frame deletion in MECP2 causes mild nonspecific mental retardation. Am J Med Genet 107:81-83.
58. Zoghbi HY, Percy kA Schulz RJ, Fill C (1990) Patterns of X chromosome inactivation in the Rett syndrome. Brain Dev 12:131-135.
59. Zweier C, Peippo MM, Hoyer J, Sousa S, Bottani A, Clayton-Smith J, Reardon W, Saraiva J, Cabral A, Gohring I, Devriendt K, de Ravel T, Bijlsma EK, Hennekam RC, Orrico A, Cohen M, Dreweke A, Reis A, Nurnberg P, Rauch A (2007) Haploinsuffi-ciency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). Am J Hum Genet 80:994-1001.